SRL
PACB icon

Scientech Research LLC’s Pacific Biosciences PACB Stock Holding History

Scientech Research LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.1K Sell
26,256
-12,194
-32% -$17.7K 0.04% 201
2026
Q1 		$50.8K Sell
38,450
-214,437
-85% -$384K 0.04% 409
2025
Q4 		$473K Buy
+252,887
New +$486K 0.3% 98
2025
Q1 		– Sell
-10,688
Closed -$19.6K – 749
2024
Q4 		$19.6K Buy
+10,688
New +$20.9K 0.01% 534

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Scientech Research LLC's PACB Position: Q2 2026 in Review

Scientech Research LLC reduced its Pacific Biosciences (PACB) stake by 32% in Q2 2026, selling an estimated $17.7K and leaving 26,256 shares worth $44.1K. The position accounts for 0.04% of the portfolio, ranked #201.

Scientech Research LLC first reported a position in PACB in Q4 2024 and has held it in 4 quarters since. The position peaked at $473K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Scientech Research LLC held 26,256 shares of Pacific Biosciences worth $44.1K as of Q2 2026.
  • Scientech Research LLC sold 12,194 Pacific Biosciences shares in Q2 2026, an estimated $17.7K.
  • Pacific Biosciences made up 0.04% of Scientech Research LLC's portfolio in Q2 2026, its #201 holding.
  • Scientech Research LLC first reported a position in Pacific Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Scientech Research LLC's Pacific Biosciences position peaked at $473K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.